title: Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
authors.affiliation: Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. carol.shields@shieldsoncology.com
authors.forename: Carol L
authors.initials: CL
authors.lastname: Shields
authors.forename: Hong
authors.initials: H
authors.lastname: Sun
authors.forename: Maria E
authors.initials: ME
authors.lastname: Manquez
authors.forename: Ann
authors.initials: A
authors.lastname: Leahey
authors.forename: Anna T
authors.initials: AT
authors.lastname: Meadows
authors.forename: Jerry A
authors.initials: JA
authors.lastname: Shields
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D005451:Fluorescein Angiography; D015355:Glaucoma, Neovascular / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D007223:Infant; D007498:Iris / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000503:physiopathology*; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D005047:Etoposide; D016190:Carboplatin